Niraparib and Copanlisib in Treating Patients With Recurrent Endometrial, Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
West German Study Group
University of Eastern Finland
Institut du Cancer de Montpellier - Val d'Aurelle
MPN Research Foundation
Università Vita-Salute San Raffaele
Yale University
M.D. Anderson Cancer Center
The University of Texas Health Science Center at San Antonio
Assistance Publique - Hôpitaux de Paris
Universität Duisburg-Essen
Institute of Hematology & Blood Diseases Hospital, China
Sun Yat-sen University
Second Xiangya Hospital of Central South University
Shanghai Chest Hospital
IRCCS San Raffaele
University of California, San Francisco
The First Hospital of Jilin University
Stanford University
Stanford University
Institut Bergonié
University of Illinois at Chicago
Centre hospitalier de l'Université de Montréal (CHUM)
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
Ain Shams University
St. Jude Children's Research Hospital
University of California, San Diego
AC Camargo Cancer Center
Universitaire Ziekenhuizen KU Leuven
Brown University
Wroclaw Medical University
Clinical Hospital Center Rijeka
IRCCS San Raffaele
M.D. Anderson Cancer Center
Norwegian University of Science and Technology
University of Pennsylvania
Weill Medical College of Cornell University
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kyorin University
University of California, San Francisco
Henan Provincial People's Hospital
Henan Provincial People's Hospital
Nanfang Hospital, Southern Medical University
University of Colorado, Denver
National Taiwan University Hospital
Massachusetts General Hospital
Chinese PLA General Hospital
Northwestern University
Istanbul Medeniyet University